Schneyer Mark C. Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
19
Insider Sells Sum
$1.57M

Insider Activity of Schneyer Mark C.

According to the SEC Form 4 filings, Schneyer Mark C., being in a position of

  1. EVP, CHIEF FINANCIAL OFFICER at Acadia Pharmaceuticals Inc.,
    оver the last 12 months, has bought 0 shares, and sold 47324 shares for $1.2M,
    over all time since 2022-02-23, has bought 0 shares, and sold 153455 shares for $3.45M.

Biography of Schneyer Mark C.

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $1,195,3708100

Comparison of Insiders on Amount of Buys and Sells

2026-10-30SaleAcadia Pharmaceuticals Inc.
ACAD
EVP, CHIEF FINANCIAL OFFICER
3,321
0.002%
$20.88$69,342-0.34%
2026-08-06SaleACADIA Pharmaceuticals Inc.
ACAD
EVP, CHIEF FINANCIAL OFFICER
14,292
0.0086%
$29.22$417,604-7.2%
2026-08-05SaleACADIA Pharmaceuticals Inc.
ACAD
EVP, CHIEF FINANCIAL OFFICER
5,849
0.0034%
$29.00$169,638-8.3%
2026-05-04SaleACADIA Pharmaceuticals Inc.
ACAD
EVP, CHIEF FINANCIAL OFFICER
3,506
0.002%
$21.79$76,396+5.27%
2026-04-07SaleACADIA Pharmaceuticals Inc.
ACAD
EVP, CHIEF FINANCIAL OFFICER
2,709
0.0016%
$22.20$60,140+0.81%
2026-03-26SaleACADIA Pharmaceuticals Inc.
ACAD
EVP, CHIEF FINANCIAL OFFICER
3,208
0.0019%
$21.65$69,456+3.59%
2026-03-25SaleACADIA Pharmaceuticals Inc.
ACAD
EVP, CHIEF FINANCIAL OFFICER
4,177
0.0024%
$21.47$89,680+0.95%
2025-11-18SaleACADIA Pharmaceuticals Inc.
ACAD
EVP, CHIEF FINANCIAL OFFICER
10,262
0.006%
$23.69$243,114-1.01%
2025-09-15SaleACADIA Pharmaceuticals Inc.
ACAD
EVP, CHIEF FINANCIAL OFFICER
3,498
0.002%
$23.65$82,728-4.5%
2025-08-18SaleACADIA Pharmaceuticals Inc.
ACAD
EVP, CHIEF FINANCIAL OFFICER
22,000
0.0131%
$25.18$554,024-5.99%
2025-05-16SaleACADIA Pharmaceuticals Inc.
ACAD
EVP, CHIEF FINANCIAL OFFICER
2,000
0.0013%
$25.00$50,000+1.53%
2025-05-02SaleACADIA Pharmaceuticals Inc.
ACAD
EVP, CHIEF FINANCIAL OFFICER
3,498
0.002%
$14.60$51,071+51.58%
2025-04-08SaleACADIA Pharmaceuticals Inc.
ACAD
EVP, CHIEF FINANCIAL OFFICER
2,708
0.0016%
$14.82$40,133+60.11%
2025-03-26SaleACADIA Pharmaceuticals Inc.
ACAD
EVP, CHIEF FINANCIAL OFFICER
3,171
0.0019%
$17.05$54,066+32.53%
2025-02-24SaleACADIA Pharmaceuticals Inc.
ACAD
EVP, CHIEF FINANCIAL OFFICER
773
0.0005%
$19.96$15,429+15.5%
2024-11-19SaleACADIA Pharmaceuticals Inc.
ACAD
EVP, CHIEF FINANCIAL OFFICER
10,259
0.0064%
$16.81$172,454+28.04%
2024-08-19SaleACADIA Pharmaceuticals Inc.
ACAD
EVP, CHIEF FINANCIAL OFFICER
9,733
0.0057%
$15.28$148,720+9.58%
2024-06-10SaleACADIA Pharmaceuticals Inc.
ACAD
EVP, CHIEF FINANCIAL OFFICER
975
0.0006%
$14.79$14,420+12.74%
2024-05-02SaleACADIA Pharmaceuticals Inc.
ACAD
EVP, CHIEF FINANCIAL OFFICER
3,503
0.0021%
$16.94$59,341-4.45%
2024-04-08SaleACADIA Pharmaceuticals Inc.
ACAD
EVP, CHIEF FINANCIAL OFFICER
2,716
0.0017%
$17.87$48,535-6.12%
Total: 30
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.